Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06693661 · ClinicalTrials.gov registry record · NA

Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease

A NA study of Kidney Diseases, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT06693661: Recruiting NA study of Kidney Diseases, sponsored by Emory University.

NCT06693661 is a NA study of Kidney Diseases that is actively recruiting participants, run by Emory University. The registered enrollment target is 600 participants, below the 1,770-participant average among 38 other Kidney Diseases trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06693661, a NA study of Kidney Diseases, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

Through the use of community-engaged processes, this project seeks to develop and implement clinical decision support (CDS) and a kidney health coaching (KHC) intervention. The CDS seeks to streamline workflows to effectively screen, identify, and link to care for those patients with advanced chronic kidney disease (CKD). The overall project goals are to 1.) Design and conduct community-engaged clinical trials to test new interventions that dismantle the systemic factors that contribute to kidney health disparities. 2.) Foster research collaborations between investigators, people living with kidney disease, community-based organizations, and other key stakeholders. Researchers aim to assess whether the KHC intervention is effective at delaying the transition to kidney replacement therapy (KRT) and central venous catheter use or death.

Primary Outcome

Composite measure of time to transition to Kidney Replacement Therapy (KRT) using a central venous catheter (CVC) over the course of the study period

Conditions Studied

Interventions

  • OTHER Kidney Health Coaching
  • OTHER Usual Care

Study Locations (1)

Georgia

  • Emory University Hospital Midtown - Atlanta

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2026-03-10
Est. Completion 2028-03
Phase NA
Emory University

1,208 total trials

What NCT06693661 shows while recruiting

NCT06693661 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,770-participant average among 38 other Kidney Diseases trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Kidney Health Coaching is the first listed.

NCT06693661 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06693661 about?

NCT06693661 is a clinical study titled "Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease". Through the use of community-engaged processes, this project seeks to develop and implement clinical decision support (CDS) and a kidney health coaching (KHC) intervention. The CDS seeks to streamline workflows to effectively screen, identify, and link to care for those patients with advanced chroni...

What is the current status of trial NCT06693661?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-03-10. Estimated completion is 2028-03.

What conditions does trial NCT06693661 study?

This clinical trial studies the following conditions: Kidney Diseases.

What interventions are being tested in trial NCT06693661?

The interventions under investigation include: Kidney Health Coaching (OTHER), Usual Care (OTHER).

Who is sponsoring clinical trial NCT06693661?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06693661 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06693661's enrollment target sits among peer trials

600 8th of 38 higher than 30 of 38 other Kidney Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06693661, the US trial registry maintained by the National Library of Medicine. NCT06693661 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.